CytRx Corp. (CYTR) Scheduled to Present at the LD Micro’s Main Event Conference in Los Angeles

CytRx Corp., a biopharmaceutical research and development company specializing in cancer treatments, announced that President and CEO Steven A. Kriegsman and Vice President of Business Development David J. Haen will be presentating at the 6th Annual LD MICRO “Main Event” Conference on Tuesday, December 3rd, 2013 at 4:00 p.m. Pacific time. The conference is being held at the Luxe Sunset Bel Air Hotel in Los Angeles.

Mr. Kriegsman and Mr. Haen will be available for one-on-one meetings with the investment community on Tuesday, December 3rd. Investors were advised to contact LD Micro organizers to schedule appointments.

Interested parties can access the audio webcast with slide presentation at http://www.cytrx.com/investors/presentations

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html